The bromodomain interaction module
暂无分享,去创建一个
[1] S. Robson,et al. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia , 2011, Nature.
[2] Thomas A. Milne,et al. Recognition of a Mononucleosomal Histone Modification Pattern by BPTF via Multivalent Interactions , 2011, Cell.
[3] Ming-Ming Zhou,et al. Brd4 Coactivates Transcriptional Activation of NF-κB via Specific Binding to Acetylated RelA , 2008, Molecular and Cellular Biology.
[4] D. Patel,et al. TRIM24 links a noncanonical histone signature to breast cancer , 2010, Nature.
[5] P. Chambon,et al. TIF1gamma, a novel member of the transcriptional intermediary factor 1 family. , 1999, Oncogene.
[6] D. Patel,et al. A Poised Chromatin Platform for TGF-β Access to Master Regulators , 2011, Cell.
[7] H. McDermid,et al. Cecr2 mutations causing exencephaly trigger misregulation of mesenchymal/ectodermal transcription factors. , 2010, Birth defects research. Part A, Clinical and molecular teratology.
[8] Xiangyuan Wang,et al. The first bromodomain of Brdt, a testis-specific member of the BET sub-family of double-bromodomain-containing proteins, is essential for male germ cell differentiation , 2007, Development.
[9] E. Salmon,et al. The human SWI/SNF-B chromatin-remodeling complex is related to yeast rsc and localizes at kinetochores of mitotic chromosomes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[10] J. Boeke,et al. The Sirtuins Hst3 and Hst4p Preserve Genome Integrity by Controlling Histone H3 Lysine 56 Deacetylation , 2006, Current Biology.
[11] S. Bhaumik,et al. Mixed lineage leukemia: histone H3 lysine 4 methyltransferases from yeast to human , 2010, The FEBS journal.
[12] P. Chambon,et al. TIF1δ, a Novel HP1-interacting Member of the Transcriptional Intermediary Factor 1 (TIF1) Family Expressed by Elongating Spermatids* , 2004, Journal of Biological Chemistry.
[13] Roman Osman,et al. Rational design of cyclic peptide modulators of the transcriptional coactivator CBP: a new class of p53 inhibitors. , 2011, Journal of the American Chemical Society.
[14] Xin Cai,et al. An acetylation switch in p53 mediates holo-TFIID recruitment. , 2007, Molecular cell.
[15] P. Chambon,et al. TIF1γ, a novel member of the transcriptional intermediary factor 1 family , 1999, Oncogene.
[16] Zhenghe Wang,et al. Differential binding modes of the bromodomains of CREB-binding protein (CBP) and p300 with acetylated MyoD. , 2008, Biochemical and biophysical research communications.
[17] Yifan Cheng,et al. The chromatin remodeler ACF acts as a dimeric motor to space nucleosomes , 2009, Nature.
[18] Michael Boutros,et al. Identification of JAK/STAT signalling components by genome-wide RNA interference , 2005, Nature.
[19] P. Marks,et al. Histone deacetylase inhibitors: molecular mechanisms of action , 2007, Oncogene.
[20] T. Parmely,et al. Identification of New Subunits of the Multiprotein Mammalian TRRAP/TIP60-containing Histone Acetyltransferase Complex* , 2003, Journal of Biological Chemistry.
[21] Mahavir Singh,et al. Structural Ramification for Acetyl‐Lysine Recognition by the Bromodomain of Human BRG1 Protein, a Central ATPase of the SWI/SNF Remodeling Complex , 2007, Chembiochem : a European journal of chemical biology.
[22] Chao Xu,et al. Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails. , 2007, Biochemistry.
[23] M. Mann,et al. Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions , 2009, Science.
[24] Y. Kanno,et al. Selective recognition of acetylated histones by bromodomain proteins visualized in living cells. , 2004, Molecules and Cells.
[25] Shigeyuki Yokoyama,et al. Structural Basis for Acetylated Histone H4 Recognition by the Human BRD2 Bromodomain* , 2010, The Journal of Biological Chemistry.
[26] B. Turner,et al. Reading signals on the nucleosome with a new nomenclature for modified histones , 2005, Nature Structural &Molecular Biology.
[27] Weiqun Shen,et al. Solution structure of the second bromodomain of Brd2 and its specific interaction with acetylated histone tails , 2007, BMC Structural Biology.
[28] D. Chaussabel,et al. SP100 inhibits ETS1 activity in primary endothelial cells , 2005, Oncogene.
[29] Jeroen Krijgsveld,et al. Cooperative binding of two acetylation marks on a histone tail by a single bromodomain , 2009, Nature.
[30] D. Wassarman,et al. TAF(II)250: a transcription toolbox. , 2001, Journal of cell science.
[31] K. Jones,et al. The multi-tasking P-TEFb complex. , 2008, Current opinion in cell biology.
[32] L. Kedes,et al. Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. , 1999, Molecular cell.
[33] Shetal Patel,et al. Mammalian ASH1L Is a Histone Methyltransferase That Occupies the Transcribed Region of Active Genes , 2007, Molecular and Cellular Biology.
[34] H. Dyson,et al. Solution structure and acetyl-lysine binding activity of the GCN5 bromodomain. , 2000, Journal of molecular biology.
[35] Roberto Sanchez,et al. Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation. , 2004, Molecular cell.
[36] Tom Misteli,et al. The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[37] D. Bowden,et al. Identification and characterization of PRKCBP1, a candidate RACK-like protein , 2000, Mammalian Genome.
[38] F. Mustafa,et al. Selective recognition of acetylated histones by bromodomains in transcriptional co-activators. , 2007, The Biochemical journal.
[39] Stefan Knapp,et al. Bromodomains as therapeutic targets , 2011, Expert Reviews in Molecular Medicine.
[40] P. Munster,et al. Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer. , 2011, Future oncology.
[41] J. Manfredi,et al. Target structure-based discovery of small molecules that block human p53 and CREB binding protein association. , 2006, Chemistry & biology.
[42] Ming-Ming Zhou,et al. A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes. , 2011, Chemistry & biology.
[43] Lei Zeng,et al. Structure and ligand of a histone acetyltransferase bromodomain , 1999, Nature.
[44] C. Rice,et al. Suppression of inflammation by a synthetic histone mimic , 2010, Nature.
[45] M. Thompson,et al. Polybromo-1-bromodomains bind histone H3 at specific acetyl-lysine positions. , 2007, Biochemical and biophysical research communications.
[46] C. Allis,et al. Translating the Histone Code , 2001, Science.
[47] K. Garber. HDAC inhibitors overcome first hurdle , 2007, Nature Biotechnology.
[48] J. Yates,et al. BRD7, a Novel PBAF-specific SWI/SNF Subunit, Is Required for Target Gene Activation and Repression in Embryonic Stem Cells* , 2008, Journal of Biological Chemistry.
[49] D. Wassarman,et al. TAFII250: a transcription toolbox , 2001 .
[50] A. El-Osta,et al. Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing , 2005, Nature Genetics.
[51] Y. Doyon,et al. Molecular Architecture of Quartet MOZ/MORF Histone Acetyltransferase Complexes , 2008, Molecular and Cellular Biology.
[52] Zhike Lu,et al. Identification of 67 Histone Marks and Histone Lysine Crotonylation as a New Type of Histone Modification , 2011, Cell.
[53] T. Kouzarides. Chromatin Modifications and Their Function , 2007, Cell.
[54] K. Marushige. Activation of chromatin by acetylation of histone side chains. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[55] I. Grummt,et al. Reversible acetylation of the chromatin remodelling complex NoRC is required for non-coding RNA-dependent silencing , 2009, Nature Cell Biology.
[56] R. Hardison,et al. Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes , 2011, Proceedings of the National Academy of Sciences of the United States of America.
[57] L. Zon,et al. TIF1γ Controls Erythroid Cell Fate by Regulating Transcription Elongation , 2010, Cell.
[58] Hongbin Sun,et al. Solution structure of BRD7 bromodomain and its interaction with acetylated peptides from histone H3 and H4. , 2007, Biochemical and biophysical research communications.
[59] J. Kushner,et al. Identification of a WD40 Repeat-Containing Isoform of PHIP as a Novel Regulator of β-Cell Growth and Survival , 2007, Molecular and Cellular Biology.
[60] B. Howard,et al. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A , 1996, Nature.
[61] Y. Liu,et al. Structural basis and binding properties of the second bromodomain of Brd4 with acetylated histone tails. , 2008, Biochemistry.
[62] S. Knapp,et al. 3,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain Ligands , 2011, Journal of medicinal chemistry.
[63] T. Richmond,et al. Crystal structure of the nucleosome core particle at 2.8 Å resolution , 1997, Nature.
[64] Helen M. Rowe,et al. KAP1 controls endogenous retroviruses in embryonic stem cells , 2010, Nature.
[65] T. Archer,et al. The BRG1 transcriptional coregulator , 2008, Nuclear receptor signaling.
[66] P. Tucker,et al. Regulation of matrix attachment region‐dependent, lymphocyte‐restricted transcription through differential localization within promyelocytic leukemia nuclear bodies , 2000, The EMBO journal.
[67] R. Young,et al. BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc , 2011, Cell.
[68] J. Nezu,et al. A novel family of bromodomain genes. , 2000, Genomics.
[69] W. Greene,et al. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF‐κB , 2002, The EMBO journal.
[70] L. Thompson,et al. Therapeutic application of histone deacetylase inhibitors for central nervous system disorders , 2008, Nature Reviews Drug Discovery.
[71] J. Lippincott-Schwartz,et al. A Bromodomain Protein, MCAP, Associates with Mitotic Chromosomes and Affects G2-to-M Transition , 2000, Molecular and Cellular Biology.
[72] Yixue Li,et al. Regulation of Cellular Metabolism by Protein Lysine Acetylation , 2010, Science.
[73] M. Pazin,et al. Histone H4-K16 Acetylation Controls Chromatin Structure and Protein Interactions , 2006, Science.
[74] Thomas A. Milne,et al. Pro Isomerization in MLL1 PHD3-Bromo Cassette Connects H3K4me Readout to CyP33 and HDAC-Mediated Repression , 2010, Cell.
[75] William B. Smith,et al. Selective inhibition of BET bromodomains , 2010, Nature.
[76] Ming-Ming Zhou,et al. Structural basis of site-specific histone recognition by the bromodomains of human coactivators PCAF and CBP/p300. , 2008, Structure.
[77] K. Helin,et al. ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors. , 2009, Cancer research.
[78] A. Revenko,et al. Chromatin Loading of E2F-MLL Complex by Cancer-Associated Coregulator ANCCA via Reading a Specific Histone Mark , 2010, Molecular and Cellular Biology.
[79] Thomas C. Kaufman,et al. brahma: A regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2 SWI2 , 1992, Cell.
[80] R Holliday,et al. The inheritance of epigenetic defects. , 1987, Science.
[81] S. Knapp,et al. Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family , 2012, Bioorganic & medicinal chemistry.
[82] He Huang,et al. Expression of the Wdr9 gene and protein products during mouse development , 2003, Developmental dynamics : an official publication of the American Association of Anatomists.
[83] S. Berger,et al. Phosphorylation of serine 10 in histone H3 is functionally linked in vitro and in vivo to Gcn5-mediated acetylation at lysine 14. , 2000, Molecular cell.
[84] Thomas A. Milne,et al. Physical Association and Coordinate Function of the H3 K4 Methyltransferase MLL1 and the H4 K16 Acetyltransferase MOF , 2005, Cell.
[85] I. Talianidis,et al. Histone modifications defining active genes persist after transcriptional and mitotic inactivation , 2005, The EMBO journal.
[86] E. Verdin,et al. Two-pronged Binding with Bromodomain-containing Protein 4 Liberates Positive Transcription Elongation Factor b from Inactive Ribonucleoprotein Complexes* , 2011, The Journal of Biological Chemistry.
[87] A. Harel-Bellan,et al. Interaction between Acetylated MyoD and the Bromodomain of CBP and / or p 300 , 2001 .
[88] Eric Verdin,et al. Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain. , 2002, Molecular cell.
[89] E. Kalkhoven,et al. CBP and p300: HATs for different occasions. , 2004, Biochemical pharmacology.
[90] C. Waddington. Preliminary Notes on the Development of the Wings in Normal and Mutant Strains of Drosophila. , 1939, Proceedings of the National Academy of Sciences of the United States of America.
[91] A. Gingras,et al. Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family , 2012, Cell.
[92] Ryan A. Flynn,et al. A unique chromatin signature uncovers early developmental enhancers in humans , 2011, Nature.
[93] S. J. Flint,et al. The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription. , 2008, Molecular cell.
[94] P. Evans,et al. The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase Gcn5p , 2000, The EMBO journal.
[95] Patrik Asp,et al. The WSTF-SNF2h Chromatin Remodeling Complex Interacts with Several Nuclear Proteins in Transcription* , 2006, Journal of Biological Chemistry.
[96] Ming-Ming Zhou,et al. Structural insights into selective histone H3 recognition by the human Polybromo bromodomain 2 , 2010, Cell Research.
[97] Jessica E. Bolden,et al. Anticancer activities of histone deacetylase inhibitors , 2006, Nature Reviews Drug Discovery.
[98] Tony Kouzarides,et al. Acetylation: a regulatory modification to rival phosphorylation? , 2000, The EMBO journal.
[99] J. Chiche,et al. Sp110 Localizes to the PML-Sp100 Nuclear Body and May Function as a Nuclear Hormone Receptor Transcriptional Coactivator , 2000, Molecular and Cellular Biology.
[100] Joel P. Mackay,et al. Structural Basis and Specificity of Acetylated Transcription Factor GATA1 Recognition by BET Family Bromodomain Protein Brd3 , 2011, Molecular and Cellular Biology.
[101] M. Geyer,et al. Interaction of propionylated and butyrylated histone H3 lysine marks with Brd4 bromodomains. , 2010, Angewandte Chemie.
[102] M. Thompson,et al. Kinetic analysis of acetylation-dependent Pb1 bromodomain-histone interactions. , 2008, Biophysical chemistry.
[103] R. Tjian,et al. Structure and function of a human TAFII250 double bromodomain module. , 2000, Science.
[104] E. Brambilla,et al. Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers , 2010, Oncogene.
[105] C. Kimmel,et al. The multidomain protein Brpf1 binds histones and is required for Hox gene expression and segmental identity , 2008, Development.
[106] D. Page,et al. Functional substitution for TAF(II)250 by a retroposed homolog that is expressed in human spermatogenesis. , 2002, Human molecular genetics.
[107] R. Bernards,et al. The adenovirus E1A binding protein BS69 is a corepressor of transcription through recruitment of N-CoR , 2000, Oncogene.
[108] D. Patel,et al. Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF , 2006, Nature.